CHARITY MITCHELL: Open Payments
NPI 1073992293 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 21 payments from 13 companies in 2025. Trend: 2023 $430 · 2024 $792 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $66 |
| ABBVIE INC. | 2 | $64 |
| Viatris Specialty LLC | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Grifols USA, LLC | 2 | $42 |
| ABIOMED | 1 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| United Therapeutics Corporation | 1 | $18 |
Products named: YUPELRI, TRELEGY ELLIPTA, DUPIXENT, TEZSPIRE, Prolastin-C Liquid, EMBLAVEO, TEFLARO, OFEV.
Industry payments across IN — which companies pay providers there.
